https://www.selleckchem.com/pr....oducts/edralbrutinib
This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.Esophageal cancer (EC) is one of the leading causes to cancer death in the worldwide and major population of EC is esophageal squamous cell carcinoma (ESCC). Still, ESCC-targeted therapy has not been covered yet. In the present study we have identified that Licochalcone B (Lico inhibited the ESCC growth by directly blocking the Janus kinase (JAK) 2 activity and its downstream signaling pathway. Lico B suppres
Like
Comment
Share
